Authors
    • Cardiovascular Disease
    • Physician at UZ Leuven

    Peter Verhamme obtained his MD at the University of Leuven (Belgium) in 1997 and began his specialist training in Internal Medicine at the University Hospital of Gasthuisberg in Leuven. He was awarded a research fellowship by the Flanders Fund for Scientific Research and started his PhD research at the Centre for Molecular and Vascular Biology in Leuven in 1998. He was a fellow at the Department of Internal Medicine of the University Hospital of Lausanne and at the Department of Angiology and Haemostasis of the University Hospital of Geneva. Since 2004 he is a staff member of the Department of Vascular Medicine and Haemostasis of the University Hospital of Gasthuisberg, Leuven. His main clinical interests are in the prevention and treatment of arterial and venous thrombosis. His research at the Center for Molecular and Vascular Biology currently centres on new antithrombotic and thrombolytic agents and on the interaction between coagulation and infection. He is actively involved in clinical trials with new antithrombotic agents.

  • Professor Rupert Bauersachs was appointed Director of the Department of Vascular Medicine at the Klinikum Darmstadt GmbH, Germany, in 2003.

    Professor Bauersachs received his medical degree from the University of Munich and was a Postdoctoral Fellow at the Department of Pharmacology, University of Munich, and subsequently a Research Fellow of the American Heart Association (AHA) at the Department of Physiology at the University of Southern California (USC), USA. Professor Bauersachs completed his residency in Internal Medicine at the München-Bogenhausen Hospital and the Universities of Mainz and Frankfurt. He is certified for Internal Medicine, Vascular Medicine, Haemostaseology, Diabetology, Phlebology, and Aviation Medicine. His main research interests include venous thromboembolism (VTE), thrombophilia, heparin-induced thrombocytopenia, microcirculation, antithrombotic agents and women’s issues in thrombosis.

    Professor Bauersachs became a faculty member of the University of Frankfurt and Head of the Department of Vascular Medicine at the University of Frankfurt in 1999. Since 2012, he has a Professorship for Vulnerable Individuals and Populations in Thrombosis and Hemostasis (VIP-TH) at the Center for Thrombosis and Hemostasis (CTH) at the University of Mainz, Germany. Professor Bauersachs is a council member for the German Societies of Angiology and Phlebology and is active in various other societies for Vascular Medicine and Thrombosis and Haemostasis. He has also published more than 100 original papers, and his scientific work has received several prizes.

    • Pulmonary Disease
    • Physician at Univ of WA

    Dr. Davidson is clinical professor of pulmonary and critical care medicine, board certified and actively practicing both, for 32 years after completing training. He has special expertise in anticoagulants and blood clots of arteries and veins, lung cancer, diseases with wheezing, and interactions of lung and heart. He graduated Haverford College and Temple University Medical School. He trained in internal medicine at University of Texas Southwestern, in pulmonary at the University of Pennsylvania, and in public health at Johns Hopkins. He served as director of Tuberculosis Control for the City of Philadelphia, as president of the National TB Controllers Association, and as senior associate dean for clinical affairs for Weill Cornell Medical College’s branch in Qatar. He is active in clinical research, co-author of seven New England Journal of Medicine, two JAMA, two Lancet, five Annals of Internal Medicine and many other research articles, and is an associate editor of the journal, CHEST.